Byrne Asset Management LLC
Source: SEC Form 13F · as of Mar 2026Byrne Asset Management LLC holds 26 biotech & pharma companies tracked by BioSniper, totaling $11.7M in value as of Mar 2026 (SEC Form 13F).
Companies held
26
Total value held
$11.7M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 18,524 | $4.5M |
| ABTABBOTT LABORATORIES | 11,681 | $1.2M |
| GEHCGE HealthCare Technologies Inc. | 16,645 | $1.2M |
| DGXQuest Diagnostics Incorporated | 5,495 | $1.1M |
| PFEPFIZER INC | 29,711 | $834K |
| LLYELI LILLY & Co | 440 | $405K |
| ABBVAbbVie Inc. | 1,850 | $402K |
| MRKMerck & Co., Inc. | 3,037 | $365K |
| GILDGILEAD SCIENCES, INC. | 2,505 | $349K |
| AMGNAMGEN INC | 977 | $344K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 1,130 | $306K |
| IQVIQVIA Holdings Inc. | 891 | $152K |
| PMPhilip Morris International Inc | 893 | $148K |
| BMYBRISTOL MYERS SQUIBB CO | 1,883 | $114K |
| NVONovo Nordisk A/S | 2,785 | $102K |
| CRVOCervoMed Inc. | 14,700 | $58K |
| ZTSZoetis Inc. | 430 | $51K |
| REGNREGENERON PHARMACEUTICALS, INC. | 22 | $17K |
| INCYIncyte Corp. | 165 | $16K |
| TEVATeva Pharmaceutical Industries Limited | 440 | $13K |
| BAXBaxter International Inc. | 420 | $7K |
| CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC. | 38 | $7K |
| IDXXIDEXX LABORATORIES INC /DE | 4 | $2K |
| LEXXLexaria Bioscience Corp. | 800 | $624 |
| AUTLAutolus Therapeutics plc | 100 | $138 |
| ELDNEledon Pharmaceuticals, Inc. | 1 | $3 |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.